BTK-IN-29 is a selective, orally active BTK degrader (IC50=0.69 nM) capable of degrading the entire BTK protein and counteracting BTK mutations. It can be used to study B-cell malignancies such as chronic lymphocytic leukemia, small lymphocytic lymphoma, mantle cell lymphoma, and others.
Molecular Weight:
851.01
Purity:
99.99%
CAS Number:
[2736508-60-2]
Formula:
C47H54N12O4
Target:
BTK|||PROTACs
* VAT and and shipping costs not included. Errors and price changes excepted